• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Delaware Healthcare Fund

+ Add to Watchlist

DLHAX:US

21.10 USD 0.09 0.42%

As of 09:29:30 ET on 09/02/2014.

Snapshot for Delaware Healthcare Fund (DLHAX)

Year To Date: +17.03% 3-Month: +11.40% 3-Year: +29.20% 52-Week Range: 16.16 - 21.19
1-Month: +3.89% 1-Year: +31.56% 5-Year: +23.79% Beta vs RGUSH: 0.96

Mutual Fund Chart for DLHAX

No chart data available.
  • DLHAX:US 21.10
  • 1M
  • 1Y
Interactive DLHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DLHAX

Delaware Healthcare Fund is an open-end fund incorporated in the USA. The Fund's objective is to maximize long-term capital growth through capital appreciation. The Fund invests at least 80% of its assets in the equity securities of health care companies.

Inception Date: 09-28-2007 Telephone: 1-800-523-1918
Managers: LIU-ER CHEN "NU"
Web Site: www.delawareinvestments.com/co/delaware

Fundamentals for DLHAX

NAV (on 2014-09-02) 21.10
Assets (M) (on 2014-09-02) 447.74
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for DLHAX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-06) 0.32
Dividend Yield (ttm) 1.99

Fees & Expenses for DLHAX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.38

Top Fund Holdings for DLHAX

Filing Date: 06/30/2014
Name Position Value % of Total
Eli Lilly & Co 555,000 34,504,350 8.415%
Teva Pharmaceutical Industries 430,000 22,540,600 5.497%
WellPoint Inc 200,000 21,522,000 5.249%
UCB SA 249,785 21,146,980 5.157%
Idenix Pharmaceuticals Inc 800,000 19,280,000 4.702%
Bristol-Myers Squibb Co 305,000 14,795,550 3.608%
Quest Diagnostics Inc 250,000 14,672,500 3.578%
Fresenius Medical Care AG & Co 207,600 13,954,142 3.403%
Chugai Pharmaceutical Co Ltd 488,300 13,760,021 3.356%
Boston Scientific Corp 1,050,000 13,408,500 3.270%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil